July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Nicholas Hornstein: The first trial to demonstrate benefit of systemic therapy in appendiceal cancer
May 22, 2024, 01:03

Nicholas Hornstein: The first trial to demonstrate benefit of systemic therapy in appendiceal cancer

Nicholas Hornstein, Oncology Fellow at MD Anderson Cancer Centre, shared a post by Cancer Research Communications on X, adding:

“Pleased to announce the first trial to demonstrate benefit of systemic therapy in appendiceal cancer. Atezolizumab and Bevacizumab; significantly improved PFS compared to synthetic cohort.

Median PFS 18.3 vs 4.4 months. Thanks to John Paul Shen and Kanwal Raghav for mentorship.” .

Quoting Cancer Research Communications’ post:

“Just published: Efficacy and safety of atezolizumab and bevacizumab in appendiceal adenocarcinoma, by Nicholas Hornstein et al.”

Source: Nicholas Hornstein/X and Cancer Research Communications/X